Forskning ved Københavns Universitet - Københavns Universitet

Forside

A randomized clinical trial of hospital-based, comprehensive cardiac rehabilitation versus usual care for patients with congestive heart failure, ischemic heart disease, or high risk of ischemic heart disease (the DANREHAB trial) - design, intervention, and population

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

A randomized clinical trial of hospital-based, comprehensive cardiac rehabilitation versus usual care for patients with congestive heart failure, ischemic heart disease, or high risk of ischemic heart disease (the DANREHAB trial) - design, intervention, and population. / Zwisler, A.D.O.; Schou, O.; Soja, A.M.B.; Bronnum-Hansen, H.; Gluud, C.; Iversen, L.; Sigurd, B.; Madsen, M.; Fischer-Hansen, J.; Danrehab, Grp.

I: American Heart Journal, Bind 150, Nr. 5, 2005, s. 899.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Zwisler, ADO, Schou, O, Soja, AMB, Bronnum-Hansen, H, Gluud, C, Iversen, L, Sigurd, B, Madsen, M, Fischer-Hansen, J & Danrehab, G 2005, 'A randomized clinical trial of hospital-based, comprehensive cardiac rehabilitation versus usual care for patients with congestive heart failure, ischemic heart disease, or high risk of ischemic heart disease (the DANREHAB trial) - design, intervention, and population', American Heart Journal, bind 150, nr. 5, s. 899. https://doi.org/10.1016/j.ahj.2005.06.010

APA

Zwisler, A. D. O., Schou, O., Soja, A. M. B., Bronnum-Hansen, H., Gluud, C., Iversen, L., Sigurd, B., Madsen, M., Fischer-Hansen, J., & Danrehab, G. (2005). A randomized clinical trial of hospital-based, comprehensive cardiac rehabilitation versus usual care for patients with congestive heart failure, ischemic heart disease, or high risk of ischemic heart disease (the DANREHAB trial) - design, intervention, and population. American Heart Journal, 150(5), 899. https://doi.org/10.1016/j.ahj.2005.06.010

Vancouver

Zwisler ADO, Schou O, Soja AMB, Bronnum-Hansen H, Gluud C, Iversen L o.a. A randomized clinical trial of hospital-based, comprehensive cardiac rehabilitation versus usual care for patients with congestive heart failure, ischemic heart disease, or high risk of ischemic heart disease (the DANREHAB trial) - design, intervention, and population. American Heart Journal. 2005;150(5):899. https://doi.org/10.1016/j.ahj.2005.06.010

Author

Zwisler, A.D.O. ; Schou, O. ; Soja, A.M.B. ; Bronnum-Hansen, H. ; Gluud, C. ; Iversen, L. ; Sigurd, B. ; Madsen, M. ; Fischer-Hansen, J. ; Danrehab, Grp. / A randomized clinical trial of hospital-based, comprehensive cardiac rehabilitation versus usual care for patients with congestive heart failure, ischemic heart disease, or high risk of ischemic heart disease (the DANREHAB trial) - design, intervention, and population. I: American Heart Journal. 2005 ; Bind 150, Nr. 5. s. 899.

Bibtex

@article{f6492a50001b11ddbee902004c4f4f50,
title = "A randomized clinical trial of hospital-based, comprehensive cardiac rehabilitation versus usual care for patients with congestive heart failure, ischemic heart disease, or high risk of ischemic heart disease (the DANREHAB trial) - design, intervention, and population",
abstract = "BACKGROUND: Current guidelines broadly recommend comprehensive cardiac rehabilitation (CR), although evidence for this is still limited. It is not known whether evidence from before 1995 is still valid. STUDY DESIGN: The DANish Cardiac ReHABilitation (DANREHAB) trial was designed as a centrally randomized clinical trial to clarify whether hospital-based comprehensive CR is superior to usual care for patients with congestive heart failure, ischemic heart disease, or high risk for ischemic heart disease. A combined primary outcome measure included total mortality, myocardial infarction, or readmissions due to heart disease based on linkage to public registries. The CR was an individually tailored, multidisciplinary program (6 weeks of intensive CR and 12 months of follow-up) including patient education, exercise training, dietary counseling, smoking cessation, psychosocial support, risk factor management, and clinical assessment. STUDY POPULATION: Of 5060 discharged patients, 1614 (32%) were eligible for the trial and 770 patients were randomized (47% of those eligible). Participants were younger (P < .001) and had less comorbidity than nonparticipants (P < .03). CONCLUSION: Our trial shows that a large-scale, centrally randomized clinical trial on comprehensive CR can be conducted among a broadly defined patient group, but reaching the stipulated number of 1800 patients was difficult. Although the study included relatively many women and older people, elderly patients and patients with high comorbidity were underrepresented, which may influence the external validity. Udgivelsesdato: 2005-Nov",
author = "A.D.O. Zwisler and O. Schou and A.M.B. Soja and H. Bronnum-Hansen and C. Gluud and L. Iversen and B. Sigurd and M. Madsen and J. Fischer-Hansen and Grp Danrehab",
note = "Keywords: Adult; Aged; Aged, 80 and over; Female; Heart Failure; Hospitalization; Humans; Male; Middle Aged; Myocardial Ischemia; Risk Factors; A randomized clinical trial of hospital-based, comprehensive cardiac rehabilitation versus usual care for patients with congestive heart failure, ischemic heart disease, or high risk of ischemic heart disease (the DANREHAB trial) - design, intervention, and population ; Conference date: 29-11-2010",
year = "2005",
doi = "10.1016/j.ahj.2005.06.010",
language = "English",
volume = "150",
pages = "899",
journal = "American Heart Journal",
issn = "0002-8703",
publisher = "Mosby Inc.",
number = "5",

}

RIS

TY - JOUR

T1 - A randomized clinical trial of hospital-based, comprehensive cardiac rehabilitation versus usual care for patients with congestive heart failure, ischemic heart disease, or high risk of ischemic heart disease (the DANREHAB trial) - design, intervention, and population

AU - Zwisler, A.D.O.

AU - Schou, O.

AU - Soja, A.M.B.

AU - Bronnum-Hansen, H.

AU - Gluud, C.

AU - Iversen, L.

AU - Sigurd, B.

AU - Madsen, M.

AU - Fischer-Hansen, J.

AU - Danrehab, Grp

N1 - Keywords: Adult; Aged; Aged, 80 and over; Female; Heart Failure; Hospitalization; Humans; Male; Middle Aged; Myocardial Ischemia; Risk Factors

PY - 2005

Y1 - 2005

N2 - BACKGROUND: Current guidelines broadly recommend comprehensive cardiac rehabilitation (CR), although evidence for this is still limited. It is not known whether evidence from before 1995 is still valid. STUDY DESIGN: The DANish Cardiac ReHABilitation (DANREHAB) trial was designed as a centrally randomized clinical trial to clarify whether hospital-based comprehensive CR is superior to usual care for patients with congestive heart failure, ischemic heart disease, or high risk for ischemic heart disease. A combined primary outcome measure included total mortality, myocardial infarction, or readmissions due to heart disease based on linkage to public registries. The CR was an individually tailored, multidisciplinary program (6 weeks of intensive CR and 12 months of follow-up) including patient education, exercise training, dietary counseling, smoking cessation, psychosocial support, risk factor management, and clinical assessment. STUDY POPULATION: Of 5060 discharged patients, 1614 (32%) were eligible for the trial and 770 patients were randomized (47% of those eligible). Participants were younger (P < .001) and had less comorbidity than nonparticipants (P < .03). CONCLUSION: Our trial shows that a large-scale, centrally randomized clinical trial on comprehensive CR can be conducted among a broadly defined patient group, but reaching the stipulated number of 1800 patients was difficult. Although the study included relatively many women and older people, elderly patients and patients with high comorbidity were underrepresented, which may influence the external validity. Udgivelsesdato: 2005-Nov

AB - BACKGROUND: Current guidelines broadly recommend comprehensive cardiac rehabilitation (CR), although evidence for this is still limited. It is not known whether evidence from before 1995 is still valid. STUDY DESIGN: The DANish Cardiac ReHABilitation (DANREHAB) trial was designed as a centrally randomized clinical trial to clarify whether hospital-based comprehensive CR is superior to usual care for patients with congestive heart failure, ischemic heart disease, or high risk for ischemic heart disease. A combined primary outcome measure included total mortality, myocardial infarction, or readmissions due to heart disease based on linkage to public registries. The CR was an individually tailored, multidisciplinary program (6 weeks of intensive CR and 12 months of follow-up) including patient education, exercise training, dietary counseling, smoking cessation, psychosocial support, risk factor management, and clinical assessment. STUDY POPULATION: Of 5060 discharged patients, 1614 (32%) were eligible for the trial and 770 patients were randomized (47% of those eligible). Participants were younger (P < .001) and had less comorbidity than nonparticipants (P < .03). CONCLUSION: Our trial shows that a large-scale, centrally randomized clinical trial on comprehensive CR can be conducted among a broadly defined patient group, but reaching the stipulated number of 1800 patients was difficult. Although the study included relatively many women and older people, elderly patients and patients with high comorbidity were underrepresented, which may influence the external validity. Udgivelsesdato: 2005-Nov

U2 - 10.1016/j.ahj.2005.06.010

DO - 10.1016/j.ahj.2005.06.010

M3 - Journal article

C2 - 16290957

VL - 150

SP - 899

JO - American Heart Journal

JF - American Heart Journal

SN - 0002-8703

IS - 5

T2 - A randomized clinical trial of hospital-based, comprehensive cardiac rehabilitation versus usual care for patients with congestive heart failure, ischemic heart disease, or high risk of ischemic heart disease (the DANREHAB trial) - design, intervention, and population

Y2 - 29 November 2010

ER -

ID: 3439621